Want to join the conversation?
$NTRS said its expenses rose 5% in 2015, reflecting investments in staffing and technology to support business growth and to comply with regulatory requirements. In the quarter, the company repurchased 2.1MM shares at a cost of $152MM and in FY15, the company returned $830MM in capital to shareholders.
$WBA is yet to receive US anti-trust clearance for its Rite Aid acquisition. The deadline for the deal expires on January 27.
$BMY plunge 7.2%. No credits to the non-acceleration of approval for lung cancer combination treatment.